Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N.

Arch Intern Med. 2010 Jun 28;170(12):1024-31. doi: 10.1001/archinternmed.2010.182. Review.

PMID:
20585067
2.
3.

Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.

Englund M, Jöud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF.

Rheumatology (Oxford). 2010 Aug;49(8):1563-9. doi: 10.1093/rheumatology/keq127. Epub 2010 May 5.

PMID:
20444855
4.

Persistence with statins and incident cataract: a population-based historical cohort study.

Chodick G, Heymann AD, Flash S, Kokia E, Shalev V.

Ann Epidemiol. 2010 Feb;20(2):136-42. doi: 10.1016/j.annepidem.2009.10.007.

PMID:
20123164
5.

Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database.

Lodi S, Evans SJ, Egger P, Carpenter J.

Br J Clin Pharmacol. 2010 Jan;69(1):85-94. doi: 10.1111/j.1365-2125.2009.03560.x.

6.

Should patients with rheumatoid arthritis receive statin therapy?

Ridker PM, Solomon DH.

Arthritis Rheum. 2009 May;60(5):1205-9. doi: 10.1002/art.24521. No abstract available.

7.

Statin adherence and risk of accidents: a cautionary tale.

Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA.

Circulation. 2009 Apr 21;119(15):2051-7. doi: 10.1161/CIRCULATIONAHA.108.824151. Epub 2009 Apr 6.

8.
9.

Continuation of statin treatment and all-cause mortality: a population-based cohort study.

Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD.

Arch Intern Med. 2009 Feb 9;169(3):260-8. doi: 10.1001/archinternmed.2008.552.

PMID:
19204217
10.

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.

Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.

Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.

PMID:
19108805
11.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group..

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

12.

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.

Jick SS, Choi H, Li L, McInnes IB, Sattar N.

Ann Rheum Dis. 2009 Apr;68(4):546-51. doi: 10.1136/ard.2008.091967. Epub 2008 Jul 28.

PMID:
18662929
14.

Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort.

Okamoto H, Koizumi K, Kamitsuji S, Inoue E, Hara M, Tomatsu T, Kamatani N, Yamanaka H.

J Rheumatol. 2007 May;34(5):964-8. Epub 2007 Apr 15.

PMID:
17444591
15.

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.

Alamanos Y, Voulgari PV, Drosos AA.

Semin Arthritis Rheum. 2006 Dec;36(3):182-8. Epub 2006 Oct 11. Review.

PMID:
17045630
16.

Estimating osteoarthritis incidence from population-based administrative health care databases.

Sun J, Gooch K, Svenson LW, Bell NR, Frank C.

Ann Epidemiol. 2007 Jan;17(1):51-6. Epub 2006 Oct 4.

PMID:
17027284
17.

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B.

Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14.

PMID:
16453090
18.

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.

Jain MK, Ridker PM.

Nat Rev Drug Discov. 2005 Dec;4(12):977-87. Review.

PMID:
16341063
19.

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA; CHARM investigators..

Lancet. 2005 Dec 10;366(9502):2005-11.

PMID:
16338449
20.

Patterns and effectiveness of lipid-lowering therapies in a managed care environment.

Meyer JW, Schultz JS, O'Donnell JC, Patel PA, Sasane RM.

Value Health. 2005 Sep-Oct;8(5):601-12.

Supplemental Content

Support Center